Exchange: NASDAQ·Updated 07:49 PM EDT
OPK logo

OPK Opko Health Inc

$1.38
$0.01
(0.73%)
Today
Closed $1.38
$0.03
(2.17%)
After Hours
EarningsOct 28
Mkt Cap$1.02B
Vol1.09M

About OPK

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment manages the clinical laboratory operations of BioReference. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and their global pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
44

Bearish Sentiment

How do you feel about OPK?

tymtested
$OPK Modex is not a drug, it is a platform and once OPKO makes it work this stock will run to $20+.. GO OPKO GO MODEX!!
8
tymtested
$OPK Zack’s has published at least 3 articles in last few days referring to Opko as strong buy! The word is getting out!
7
tymtested
$OPK consider that as Frost holds $70M in converts, the equivalent of about 61M shares, he gains enormous amount of ownership without having to file a form 4 or come under the scrutiny of an insider making a huge purchase on open market because "he knows something". He also is averaging down, something that smart investors are doing now.
6
TommyCotton
$OPK For anyone wondering about yesterday’s drop, I haven’t found any new negative company or ModeX news that explains it. The convertible-note conversion window could be creating some dilution/selling concern, but that’s only a possibility. Meanwhile, Zacks itself confirmed Monday that OPK is now a Zacks Rank #1 (Strong Buy). No new negative MDX2001, Merck EBV, BARDA or other ModeX development that I can find. For now, yesterday looks more like market/share-structure pressure than a change in the underlying story.
1
3
JV932
$OPK Modex came in 4 years ago and walked into a mess from all directions. They have been cleaning house and restructuring ever since. What opko was 10/20 years ago is not what it is today. Modex has redefined everything and in time, we opko bag holders will reap the benefits. Not sure why the ticker opk hasn't been replace with mdx. JMO
5
TommyCotton
$OPK Zacks has reportedly upgraded OPKO from Hold to Strong Buy. One analyst change doesn’t prove the turnaround, but it’s encouraging to see sentiment beginning to improve ahead of the upcoming ModeX clinical data and Merck EBV decision. The real test remains the data, but the pieces continue to get more interesting.
5
Gasbagger
$OPK Opko didnt need the 250 million dollars it borrowed at 7 percent. Why not give the Longs that 7 percent instead ? Ill tell you why. Every thing is only for Frost and Friends .
5
TommyCotton
$OPK What I like more about the situation today than several months ago is that the thesis is becoming testable. We’re getting past “ModeX has interesting technology” and approaching “show us what it actually does in people.” If the answer is good, then we can start talking much more seriously about what ModeX itself might be worth—not merely whether OPK can get through $2. At the very least, it is interesting what has objectively changed around OPKO. The stock has spent enough time above $1.495 to trigger the convertible-note provision—that alone tells us the $1.50–$1.70 area has been much more durable than the brief spikes we’ve seen before. And recent information says OPK is up roughly 32.5% year-to-date, with the improving pharmaceutical business, partnerships and approaching clinical milestones contributing to the change in sentiment.
4
tradertrash
$OPK Or...are they building up cash for the new owners 🤔, ill be looking for the last of the labs to be sold next, just my thoughts and they are worth nothing
4
JV932
$OPK The volume remains very thin. I would be extra worried if volume was extremely high which would put pressure on the sp. These setbacks will only set us up for the real upside. Modex has plenty of reasons to be optimistic and hopeful. These are trial times for all of us. Don't let your judgement get in the way of what's coming. The fundamentals have not changed that I know of. This is a time to be greedy. JMO
3
JV932
$OPK I figured with the note getting payed off with further dilution that the market would digest it fairly well. Then again, I guess the market is tired of so much dilution. The volume has been so low for the last several days that profit taking alone might be driving this price down. The bid is getting hammered with no counter buying as of yet. I see a bounce in the coming days after everything calms down and buyers step in to take advantage of the vicious pullback.
3
tradertrash
$OPK always tomorrow... for some reason 🙄 they never can deliver today❓ ray & hgh are successful, it's just sh never get to share in that success, but u can bet they never miss a raise or bonus or stock option, for a complete failure to sh, it's been years ive heard that tomorrow bs, they just keep funding, without showing any return for sh, gets old, same old sh*t, rinse & repeat
3
Mike18181
$OPK $1.35 Per share is whats really going on behind tbe curtain, Opko has graded it self with this value, All other companies of tbis size are not in this Delema, Keep borrowing to stay a float S*A*D
1
Brasil07
$OPK the only One good thing that Mr. Frost can do for all the shareholders.....Is : pass away!
2
tradertrash
$OPK cashing in royalties early for more cash to burn is always a good sign 😱 so toxic imo
2
Gasbagger
$OPK Speaking at the Wells Fargo Healthcare Conference, President and Vice Chairman Elias Zerhouni said,a GLP-1/glucagon candidate in Phase I development.**OPK-8801001**,is at the investigational new drug stage and expects to enter clinical trials in the following month.A **CAR-T program,** a first clinical trial is expected at the end of the year or early next year.MDX-2001,with potential results expected early next year.OPKO expects Merck to make a decision on how to proceed in the near term, he said.He added that OPKO expects to pursue additional partnerships because it does not intend to independently fund every program through later stages. In every statement Zerhouni made he said EXPECTS. That is not definite. So it seems everything has been at a standstill for quite sometime . So what has 35 MILLION in R&D every quarter being spent on ?
2
Gasbagger
$OPK Everything Opko has done has been a failure for Shareholders,but yet ,Frost and Friends keep reaping big pay days. From all of his self serving investments ,Cocp,Entx ,Vbiv,Shareholders never received ONE SHARE of anything. Frost now wants you to believe in ModeX as all the cash is disappearing.
2
Mike18181
$OPK Insider trading, politics, and piwer have a seperate rulebook. " the untouchables". Pandemic , now 100+ oil. Recklass behaviour to stakeholders is also Frost. IMO Impeach trump and Netan-yahoo has shown his ASS. Hes all talk !
2
magadog
$OPK Never fails One of the original clowns shows up at some conference and, boom, reminds people how full of crap the company executives are
2
Brasil07
$OPK today Is the bio Sector in big trouble, I saw Moderna,Novavax, and many others all are down minimum 7/10 %
1

Advertisement|Remove ads.